Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA

Friendly Bacteria Found in Probiotic Drinks May Shrink Solid Tumors

By BiotechDaily International staff writers
Posted on 15 Apr 2013
Friendly bacteria typically found in probiotic drinks could be used to shrink tumors, according to new research.

Researchers, from the University of Ulster (Northern Ireland) and Sonidel, Ltd. (Dublin, Ireland), examined the effect on tumors of the common Lactobacillus casei, which is found in the gut and human mouth, and a substance used in many probiotic drinks.

When injected directly into tumors, the new findings suggest that L. Casei could suppress tumor growth. Earlier studies suggest that specific kinds of bacteria grow well in solid tumors, which created the potential to use these kinds of bacteria to degrade tumors from the inside out. This study was structured to evaluate the hypothesis using a harmless kind of bacteria—L. Casei was a good candidate.

The researchers cultured the bacteria in beads, inside a growth solution. The research revealed that the bacteria generate molecules that are toxic to tumors. To further assess the hypothesis, the researchers then injected the encapsulated bacteria directly into tumors in lab mice. The bacteria substantially suppressed tumor growth. These research findings suggest that this approach has a potential therapeutic benefit in the treatment of solid tumors.

The study’s findings were published December 2012 in the International Journal of Medical Microbiology.

Related Links:

University of Ulster
Sonidel




Channels

Genomics/Proteomics

view channel
Image: Pulsed near infrared light (shown in red) is shone onto a tumor (shown in white) that is encased in blood vessels. The tumor is imaged by photoacoustic tomography via the ultrasound emission (shown in blue) from the gold nanotubes (Photo courtesy of Jing Claussen (iThera Medical, Germany)).

Gold Nanotubes Are Novel Agents for Cancer Diagnosis and Treatment

Cancer researchers have produced a highly defined class of gold nanotubes that are suitable for use in animals as in vivo imaging nanoprobes, photothermal conversion agents, and drug delivery vehicles.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Lab Technologies

view channel
Image: The FLUOVIEW FVMPE-RS Gantry microscope (Photo courtesy of Olympus).

New Multiphoton Laser Scanning Microscope Configurations Expand Research Potential

Two new configurations of a state-of-the-art multiphoton laser scanning microscope extend the usefulness of the instrument for examining rapidly occurring biological events and for obtaining images from... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.